Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices in...
Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance
Shanghai HeartCare proposes bylaw amendments ahead of planned Shanghai STAR listing
The Filter of Capital and Value Chain Realignment: Hong Kong's Market Bifurcation in 2026
Mid-Year Reality Check: Earnings Surprises and Aerospace Pivots in Hong Kong
The Great Reallocation: From Physical Moats to AI Marginal Cost Revolutions
Shanghai HeartCare Signals Strong Interim Profit and Revenue Surge